Baseline NT‐proBNP Accurately Predicts Symptom Response to Transcatheter Aortic Valve Implantation

Baseline NT‐proBNP Accurately Predicts Symptom Response to Transcatheter Aortic Valve Implantation

Background Up to 30% of patients undergoing transcatheter aortic valve implantation (TAVI) experience minimal symptomatic benefit or die within 1 year, indicating an urgent need for enhanced patient selection. Previous analyses of baseline NT‐proBNP (N‐terminal pro‐brain natriuretic peptide) and TAV...

Full description

Bibliographic Details
Main Authors: Christopher J. Allen, Jubin Joseph, Tiffany Patterson, Matthew Hammond‐Haley, Hannah Z. R. McConkey, Bernard D. Prendergast, Michael Marber, Simon R. Redwood
Format: Article
Language:English
Published: Wiley 2020-12-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
aortic stenosis
NT‐proBNP
transcutaneous aortic valve implantation
transfemoral aortic valve implantation
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.120.017574

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.120.017574

Similar Items